 
 
|
Combipure
was formed in 1999.
Combipure’s aim then as now is to provide a rapid high quality
combinatorial library screening and purification service using
unique pioneering technologies and protocols.
Our mission is to become indispensable to the pharmaceutical
industry by partnering with and accelerating the drug discovery
process.
Successive years of rapid growth and increasing workloads from
major pharmaceutical companies necessitated a new level of automation
and data processing.
Further enhanced throughput was achieved by employing additional
in-house technical resource and the subsequent development of
a number of novel software and hardware technologies.
Today the five Scientific Executive Directors consist of ex-
AstraZeneca and Hewlett Packard/Agilent Technology employees,
bringing over 90 years of Analytical and Pharmaceutical experience
to the company.
The mainstays of Combipure’s business include:
 Compound
Library Purity Screening (QA)
Compound
Library Purification
Synthesis
of customised Combinatorial Libraries and Building Blocks
Being at the for-front of technology ensures that our clients
receive the highest quality results in the fastest turnaround
time with minimum overhead.
|
|
|
